Radiation-induced lung injury—current perspectives and management

MS Rahi, J Parekh, P Pednekar, G Parmar… - Clinics and …, 2021 - mdpi.com
Radiotherapy plays an important role in the treatment of localized primary malignancies
involving the chest wall or intrathoracic malignancies. Secondary effects of radiotherapy on …

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges

N Kewalramani, C Machahua, V Poletti… - ERJ open …, 2022 - Eur Respiratory Soc
Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity
and mortality. Lung fibrosis can be associated with lung cancer. The pathogenesis of both …

Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients

B Li, G Ren, W Guo, J Zhang, SK Lam… - Frontiers in …, 2022 - frontiersin.org
Purpose: This study investigates the impact of lung function on radiation pneumonitis
prediction using a dual-omics analysis method. Methods: We retrospectively collected data …

Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice

T Karampitsakos, F Sampsonas… - Current Opinion in …, 2023 - journals.lww.com
Management of patients with idiopathic pulmonary fibrosis an... : Current Opinion in Pulmonary
Medicine Management of patients with idiopathic pulmonary fibrosis and lung cancer …

[HTML][HTML] Fatal radiation pneumonitis: literature review and case series

S Keffer, CL Guy, E Weiss - Advances in Radiation Oncology, 2020 - Elsevier
Purpose Fatal radiation pneumonitis is a rare event. In recent years, higher incidences of
grade 5 pneumonitis have been reported. Based on 3 cases in our clinic, a literature review …

[PDF][PDF] Diagnosis and treatment of lung cancer in the setting of interstitial lung disease

DA Fisher, MC Murphy, SB Montesi, LP Hariri… - Radiologic Clinics of …, 2022 - Elsevier
In the setting of ILD, patients are at increased risk for lung cancer. The diagnosis and
treatment of lung cancer at any stage is challenging in the setting of ILD, especially in …

Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall …

T Yamamoto, Y Tsukita, Y Katagiri, H Matsushita… - BMC cancer, 2022 - Springer
Background In clinical practice, the effect of durvalumab and radiation pneumonitis (RP) on
survival after intensity-modulated radiotherapy (IMRT) is not fully understood. The purpose …

Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis

JZ Peng, ZX Bie, YM Li, RQ Guo, XG Li - European Radiology, 2024 - Springer
Objectives To evaluate the safety and efficacy of microwave ablation (MWA) for stage I non-
small cell lung cancer (NSCLC) in patients with idiopathic pulmonary fibrosis (IPF). Materials …

Hypofractionated proton beam therapy for cT1-2N0M0 non-small cell lung cancer patients with interstitial lung disease

T Saito, K Ohnishi, H Ishikawa, M Nakamura… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage
non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients …

Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy

F Li, H Liu, H Wu, S Liang, Y Xu - Radiation Oncology, 2021 - Springer
Background Previous studies have found that patients with subclinical interstitial lung
disease (ILD) are highly susceptible to developing radiation pneumonitis (RP) after thoracic …